Secondary primary malignancies after treatment with chemo-immunotherapy in treatment-naïve patients with CLL: a systematic literature review
Marcell Csanádi(Syreon Research Institute (Hungary)), Κώστας Σταματόπουλος(Centre for Research and Technology Hellas), Tamás Ágh(Syreon Research Institute (Hungary)), Christoph Tapprich(Johnson & Johnson (Germany)), Attila Tordai(Semmelweis University), Zoltán Vokó(Semmelweis University)
Cited by 3
Related Papers
Non-coding recurrent mutations in chronic lymphocytic leukaemia
|Nature|2015|851
Molecular Subsets of Mantle Cell Lymphoma Defined by the <i>IGHV</i> Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features
|Cancer Research|2012|252